Dotan I - Search Results

1

Comprehensive pouch clinic concept for follow-up of patients after ileal pouch anal anastomosis: report of 3 years' experience in a tertiary referral center.

Tulchinsky H, Dotan I, Alper A, Brazowski E, Klausner JM, Halpern Z, Rabau M. Tulchinsky H, et al. Among authors: dotan i. Inflamm Bowel Dis. 2008 Aug;14(8):1125-32. doi: 10.1002/ibd.20430. Inflamm Bowel Dis. 2008. PMID: 18338779

2

Inhibition of experimentally induced cirrhosis in rats by hypothyroidism.

Oren R, Dotan I, Papa M, Marravi Y, Aeed H, Barg J, Zeidel L, Bruck R, Halpern Z. Oren R, et al. Among authors: dotan i. Hepatology. 1996 Aug;24(2):419-23. doi: 10.1053/jhep.1996.v24.pm0008690414. Hepatology. 1996. PMID: 8690414

3

Thyroxine accelerates proliferation of injured liver cells.

Oren R, Resnick MB, Brill S, Dotan I, Zaidel L, Lifshits-Mercer B, Halpern Z. Oren R, et al. Among authors: dotan i. J Hepatol. 1998 Oct;29(4):634-7. doi: 10.1016/s0168-8278(98)80159-1. J Hepatol. 1998. PMID: 9824273

4

Liver function in cirrhotic patients in the euthyroid versus the hypothyroid state.

Oren R, Brill S, Dotan I, Halpern Z. Oren R, et al. Among authors: dotan i. J Clin Gastroenterol. 1998 Dec;27(4):339-41. doi: 10.1097/00004836-199812000-00012. J Clin Gastroenterol. 1998. PMID: 9855265

5

Altered thyroid status modulates portal pressure in normal rats.

Oren R, Dotan I, Brill S, Jones BE, BenHaim M, Sikuler E, Halpern Z. Oren R, et al. Among authors: dotan i. Liver. 1999 Oct;19(5):423-6. doi: 10.1111/j.1478-3231.1999.tb00072.x. Liver. 1999. PMID: 10533801

6

[Treatment of Crohn's disease with anti TNF alpha antibodies--the experience in the Tel Aviv Medical Center].

Dotan I, Yeshurun D, Hallak A, Horowitz N, Tiomny E, Reif S, Halpern Z, Rachmilewitz D. Dotan I, et al. Harefuah. 2001 Apr;140(4):289-93, 368. Harefuah. 2001. PMID: 11303390 Clinical Trial. Hebrew.

7

Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats.

Dotan I, Hershkoviz R, Karmeli F, Brazowski E, Peled Y, Rachmilewitz D, Halpern Z. Dotan I, et al. Aliment Pharmacol Ther. 2001 Oct;15(10):1687-97. doi: 10.1046/j.1365-2036.2001.01079.x. Aliment Pharmacol Ther. 2001. PMID: 11564011

8

Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial.

Dotan I, Hallak A, Arber N, Santo M, Alexandrowitz A, Knaani Y, Hershkoviz R, Brazowski E, Halpern Z. Dotan I, et al. Dig Dis Sci. 2001 Oct;46(10):2239-44. doi: 10.1023/a:1011979418914. Dig Dis Sci. 2001. PMID: 11680603

9

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.

Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z. Dotan I, et al. Among authors: dotan n. Gastroenterology. 2006 Aug;131(2):366-78. doi: 10.1053/j.gastro.2006.04.030. Gastroenterology. 2006. PMID: 16890590

10

Inflammatory bowel disease is not associated with increased intimal media thickening.

Maharshak N, Arbel Y, Bornstein NM, Gal-Oz A, Gur AY, Shapira I, Rogowski O, Berliner S, Halpern Z, Dotan I. Maharshak N, et al. Among authors: dotan i. Am J Gastroenterol. 2007 May;102(5):1050-5. doi: 10.1111/j.1572-0241.2007.01086.x. Epub 2007 Feb 21. Am J Gastroenterol. 2007. PMID: 17313498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters